Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)

Last updated: September 18, 2026
Sponsor: University of Alabama at Birmingham
Overall Status: Completed

Phase

N/A

Condition

Diabetes And Hypertension

Diabetes Prevention

Diabetes Mellitus, Type 2

Treatment

Digital Health Coaching

Food Box Delivery

Remote Patient Monitoring (RPM)

Clinical Study ID

NCT05288452
IRB-300008387
5P50MD017338-03
  • Ages > 18
  • All Genders

Study Summary

Brief Summary:

The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adults in the Deep South. The intervention targets social determinants of health (SDoH) such as reduced healthcare access, poverty, transportation barriers, and food insecurity.

Eligibility Criteria

Inclusion

Inclusion criteria:

  1. Self-identified as Black/African American

  2. ICD diagnosis of T2DM

  3. ≥18 years of age

  4. Ongoing insulin treatment

  5. HbA1c ≥8% within 6 weeks of study screening

  6. has the ability to converse in and read English

  7. must provide written informed consent prior to enrollment

Exclusion

Exclusion criteria:

  1. Current enrollment in any diabetes-related interventional study

  2. Cognitive impairment

  3. End-stage kidney disease (CKD-5)

  4. Pregnant or plans to become pregnant within 12 months

  5. Currently enrolled in a structured lifestyle change program

  6. Enrolled in remote patient monitoring or health coaching within 60 days of the studyor intervention

HIV Cohort Criteria

Inclusion Criteria

  1. ≥ 18 years of age

  2. ICD diagnosis of T2DM

  3. HbA1c ≥ 7%

  4. Confirmed HIV+ diagnosis

  5. Prescribed HIV ART therapy as part of care

Exclusion Criteria

  1. Current enrollment in any diabetes-related interventional study or structuredlifestyle change program

  2. Enrolled in RPM or health coaching (except for coaching on smoking cessation) within 60 days of the intervention

  3. Cognitive impairment

  4. End-stage kidney disease (CKD-5)

  5. Pregnant or plans to become pregnant within 12 months

Study Design

Total Participants: 304
Treatment Group(s): 4
Primary Treatment: Digital Health Coaching
Phase:
Study Start date:
January 05, 2023
Estimated Completion Date:
August 30, 2026

Study Description

Detailed Description:

  1. FREEDOM Study (Type 2 Diabetes Mellitus):

    The FREEDOM study is a 12-month clinical trial enrolling 304 Black adults with Type 2 Diabetes Mellitus across three healthcare systems in Alabama and Mississippi. Participants are randomly assigned to one of eight combinations of three intervention components:

    • Digital Health Coaching: Participants receive one-on-one phone-based coaching for optimized diabetes management.

    • Food Box Delivery: Food boxes are delivered every two weeks to participants' homes,

    • Remote Patient Monitoring (RPM): Participants receive essential supplies, including glucometers, for remote blood glucose measurement. Data is monitored remotely for timely interventions.

    The study involves three in-person visits at baseline, month 6, and month 12, as well as two telephone study check-ins at month 3 and 9. Survey packets are administered at each time point.

  2. FREEDOM-HIV Study (Type 2 Diabetes Mellitus and HIV Cohort):

Additionally, a cohort within the study, known as the FREEDOM-HIV study, will enroll additional 80 adults who have both Type 2 Diabetes Mellitus and HIV. This cohort will be observed over a 6-month period and will also consist of the same three intervention components.

Connect with a study center

  • UAB Hospital and UMMC Cardiology Clinics

    Birmingham, Alabama 35205
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 609.945.0101

Trademark Disclaimer

WCG’s Clinical Trial Listing Service (CTLS) is an online database of clinical research studies curated from public and proprietary sources.

Any references to third-party entities, companies, brands, trademarks, service marks, or logos are provided solely for informational purposes. Such references do not imply any endorsement, sponsorship, authorization, recommendation, partnership, or other affiliation between WCG and any such third party.